Company Cognetivity Neurosciences Ltd.

Equities

CGN

CA19243C1005

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Quarterly revenue - Rate of surprise

Sector Medical Software & Technology Services

Delayed Canadian Securities Exchange Other stock markets 01:52:01 2024-04-25 pm EDT			5-day change	1st Jan Change
0.02 ^CAD	0.00%		+33.33%	+33.33%

2023	Cognetivity Neurosciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	CI
2023	Cognetivity Neurosciences Ltd. announced that it has received CAD 0.01 million in funding	CI

Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial and consumer environments for potentially allowing early diagnosis of dementia. The Companyâs ICA uses artificial intelligence and machine learning techniques to detect the earliest signs of cognitive impairment by testing the performance of brain. Its products include CognICA and OptiMind. The CognICA has various applications from providing a measure of cognitive function, to long-term health monitoring, corporate wellness, and personalized brain health. The OptiMind is a wellness app that measures individuals everyday cognitive performance. The Company serves various industries, including healthcare, elder care, enterprise, everyday use, and research. The ICA is available for clinical use in the United States of America, United Kingdom and Europe.

CAD in Million	2022	Weight	2023	Weight	Delta
Integrated Cognitive Assessment 100.0 %	0	nan %	0	100.0 %	-

CAD in Million	2022	Weight	2023	Weight	Delta
United Kingdom 100.0 %	0	nan %	0	100.0 %	-

Managers	Title	Age	Since
Seyed-Mahdi Khaligh-Razavi FOU	Founder	35	19-01-07
Sina Habibi FOU	Founder	43	13-03-31
Thomas Sawyer DFI	Director of Finance/CFO	54	19-01-07
Mark Phillips CMP	Compliance Officer	65	17-12-20

Members of the board	Title	Age	Since
Desmond Balakrishnan BRD	Director/Board Member	52	-
Karimah Es Sabar BRD	Director/Board Member	66	23-04-19
Sina Habibi FOU	Founder	43	13-03-31
Mark Phillips CMP	Compliance Officer	65	17-12-20

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	89,556,611	76,627,970 ( 85.56 %)	0	85.56 %
Stock B	0	14,760,270	0	0

Name	Equities	%	Valuation
Sina Habibi 10.16 %	9,104,314	10.16 %	127 460 $
Seyed-Mahdi Khaligh-Razavi 8.587 %	7,692,565	8.587 %	107 696 $
Next Edge Capital Corp. 1.490 %	1,334,500	1.490 %	18 683 $
Christos Kalafatis 1.483 %	1,328,619	1.483 %	18 601 $
Thomas Sawyer 1.363 %	1,220,666	1.363 %	17 089 $
Mark Phillips 0.9108 %	815,934	0.9108 %	11 423 $
David Velisek 0.1674 %	150,000	0.1674 %	2 100 $

Cognetivity Neurosciences Ltd.

1055 West Hastings Street Suite 2250

V6E 2E9, Vancouver

http://cognetivity.com

address Cognetivity Neurosciences Ltd.(CGN)

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Software & Technology Services

	1st Jan change	Capi.
COGNETIVITY NEUROSCIENCES LTD.	+33.33%	1.37M
VEEVA SYSTEMS INC.	+4.55%	32.58B
PRO MEDICUS LIMITED	+16.26%	7.65B
SECTRA AB	+21.60%	3.92B
EVOLENT HEALTH, INC.	-17.20%	3.19B
OMNICELL, INC.	-28.65%	1.26B
LUNIT INC.	-33.58%	1.14B
B-SOFT CO.,LTD.	-33.74%	926M
SIMULATIONS PLUS, INC.	+0.63%	908M
VERADIGM INC.	-26.12%	859M

Medical Software & Technology Services